Clinical Trials in Puyang, China
Locations / Puyang, China
Delta Trials hosts 47 clinical trials conducted in Puyang, China, making it a notable site of clinical research activity. These trials covering 67 medical conditions and multiple therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 1 trial in this location have been stopped, mirroring broader trends in global research activity. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, tracking research history across multiple versions for Puyang.
47
Total Trials
67
Conditions
1
Terminated since 2020
Browse by condition (67 total)
- All Chronic obstructive pulmonary disease trials
- Ischemic stroke, acute 4 trialsAll Ischemic stroke, acute trials
- All Pulmonary disease, chronic obstructive trials
- Endovascular treatment 2 trialsAll Endovascular treatment trials
- Ischemic stroke 2 trialsAll Ischemic stroke trials
- All St segment elevation myocardial infarction trials
- Thrombosis 2 trialsAll Thrombosis trials
- Acute ischemic stroke 2 trialsAll Acute ischemic stroke trials
- Hyperkalemia 2 trialsAll Hyperkalemia trials
- Vascular closure 1 trialAll Vascular closure trials
- Coronary artery disease (cad) 1 trialAll Coronary artery disease (cad) trials
- Nsclc 1 trialAll Nsclc trials
- All Advanced gastric or gastroesophageal junction adenocarcinoma trials
- Puncture 1 trialAll Puncture trials
- All Primary percutaneous coronary intervention trials
- Human papillomavirus infection 1 trialAll Human papillomavirus infection trials
- Hepatocellular carcinoma 1 trialAll Hepatocellular carcinoma trials
- Transient ischemic attack 1 trialAll Transient ischemic attack trials
- Arteriosclerosis 1 trialAll Arteriosclerosis trials
- Breast cancer 1 trialAll Breast cancer trials